Compile Data Set for Download or QSAR
maximum 50k data
Report error Found 223 with Last Name = 'shinohara' and Initial = 't'
TargetVasopressin V2 receptor(Human)
Otsuka Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM35723(CHEMBL344159 | N-[4-(7-Chloro-5-hydroxy-2,3,4,5-te...)
Affinity DataKi:  0.430nMAssay Description:Concentration of the compound which inhibit [3H]-AVP binding to human Vasopressin V2 receptor coded HeLa cells by 50%More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetVasopressin V2 receptor(Human)
Otsuka Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM35714(CHEMBL420762 | Mozavaptan | N-[4-(5-Dimethylamino-...)
Affinity DataKi:  9.42nMAssay Description:Concentration of the compound which inhibit [3H]-AVP binding to human Vasopressin V2 receptor coded HeLa cells by 50%More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetVasopressin V1a receptor(Rat)
Otsuka Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50029644(CHEMBL296908 | N-(3-(4-(4-(2-oxo-3,4-dihydroquinol...)
Affinity DataKi:  32nMAssay Description:Binding affinity of the compound towards Vasopressin V1a receptor in rat liverMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetVasopressin V1a receptor(Human)
Otsuka Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50029644(CHEMBL296908 | N-(3-(4-(4-(2-oxo-3,4-dihydroquinol...)
Affinity DataKi:  1.40E+4nMAssay Description:Binding affinity of the compound towards Vasopressin V1a receptor in human liverMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetVasopressin V2 receptor(Human)
Otsuka Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50094076(CHEMBL434654 | N-[4-(7-Chloro-2,3,4,5-tetrahydro-b...)
Affinity DataIC50:  0.950nMAssay Description:Concentration of the compound which inhibit [3H]-AVP binding to human Vasopressin V2 receptor coded HeLa cells by 50%More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetVasopressin V2 receptor(Human)
Otsuka Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50094079((4-Amino-2-methyl-phenyl)-(7-chloro-2,3,4,5-tetrah...)
Affinity DataIC50:  4.10nMAssay Description:Inhibition of [3H]-AVP binding to human Vasopressin V2 receptor expressed in HeLa cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetVasopressin V2 receptor(Human)
Otsuka Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50094068((2-Chloro-4-ethylamino-phenyl)-(7-chloro-2,3,4,5-t...)
Affinity DataIC50:  5nMAssay Description:Inhibition of [3H]-AVP binding to human Vasopressin V2 receptor expressed in HeLa cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetVasopressin V2 receptor(Human)
Otsuka Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50094086((4-Allylamino-2-chloro-phenyl)-(2,3,4,5-tetrahydro...)
Affinity DataIC50:  5.90nMAssay Description:Inhibition of [3H]-AVP binding to human Vasopressin V2 receptor expressed in HeLa cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetVasopressin V2 receptor(Human)
Otsuka Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50094082((2-Chloro-4-pyrrol-1-yl-phenyl)-(2,3,4,5-tetrahydr...)
Affinity DataIC50:  7.5nMAssay Description:Inhibition of [3H]-AVP binding to human Vasopressin V2 receptor expressed in HeLa cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetVasopressin V2 receptor(Human)
Otsuka Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50094066((2-Chloro-4-pyrazol-1-yl-phenyl)-(2,3,4,5-tetrahyd...)
Affinity DataIC50:  8.80nMAssay Description:Inhibition of [3H]-AVP binding to human Vasopressin V2 receptor expressed in HeLa cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetVasopressin V2 receptor(Human)
Otsuka Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50094075((2-Chloro-4-pyrrolidin-1-yl-phenyl)-(2,3,4,5-tetra...)
Affinity DataIC50:  9nMAssay Description:Inhibition of [3H]-AVP binding to human Vasopressin V2 receptor expressed in HeLa cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetVasopressin V2 receptor(Human)
Otsuka Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50094075((2-Chloro-4-pyrrolidin-1-yl-phenyl)-(2,3,4,5-tetra...)
Affinity DataIC50:  9nMAssay Description:Binding affinity of the compound against human Vasopressin V2 receptor expressed in HeLa cells was determinedMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetVasopressin V2 receptor(Human)
Otsuka Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50094074((2-Chloro-4-dimethylamino-phenyl)-(7-chloro-2,3,4,...)
Affinity DataIC50:  13nMAssay Description:Inhibition of [3H]-AVP binding to human Vasopressin V2 receptor expressed in HeLa cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetVasopressin V2 receptor(Human)
Otsuka Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50094070(CHEMBL136109 | [2-Chloro-4-(3-methyl-pyrazol-1-yl)...)
Affinity DataIC50:  13nMAssay Description:Inhibition of [3H]-AVP binding to human Vasopressin V2 receptor expressed in HeLa cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetVasopressin V2 receptor(Human)
Otsuka Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50094072((2-Chloro-4-pyrrolidin-1-yl-phenyl)-(7-chloro-2,3,...)
Affinity DataIC50:  16nMAssay Description:Inhibition of [3H]-AVP binding to human Vasopressin V2 receptor expressed in HeLa cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetVasopressin V2 receptor(Human)
Otsuka Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50094067((2-Chloro-4-dimethylamino-phenyl)-(2,3,4,5-tetrahy...)
Affinity DataIC50:  18nMAssay Description:Inhibition of [3H]-AVP binding to human Vasopressin V2 receptor expressed in HeLa cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetVasopressin V2 receptor(Human)
Otsuka Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50094089((2-Chloro-4-propylamino-phenyl)-(2,3,4,5-tetrahydr...)
Affinity DataIC50:  18nMAssay Description:Inhibition of [3H]-AVP binding to human Vasopressin V2 receptor expressed in HeLa cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetVasopressin V2 receptor(Human)
Otsuka Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50094077((2-Chloro-4-diethylamino-phenyl)-(2,3,4,5-tetrahyd...)
Affinity DataIC50:  19nMAssay Description:Inhibition of [3H]-AVP binding to human Vasopressin V2 receptor expressed in HeLa cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetVasopressin V2 receptor(Human)
Otsuka Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50094078((4-Butylamino-2-chloro-phenyl)-(2,3,4,5-tetrahydro...)
Affinity DataIC50:  22nMAssay Description:Inhibition of [3H]-AVP binding to human Vasopressin V2 receptor expressed in HeLa cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetVasopressin V2 receptor(Human)
Otsuka Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50094087((2-Chloro-4-pentylamino-phenyl)-(2,3,4,5-tetrahydr...)
Affinity DataIC50:  31nMAssay Description:Inhibition of [3H]-AVP binding to human Vasopressin V2 receptor expressed in HeLa cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetVasopressin V2 receptor(Human)
Otsuka Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50094069((2-Chloro-4-ethylamino-phenyl)-(2,3,4,5-tetrahydro...)
Affinity DataIC50:  34nMAssay Description:Inhibition of [3H]-AVP binding to human Vasopressin V2 receptor expressed in HeLa cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetVasopressin V2 receptor(Human)
Otsuka Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50094083((2-Chloro-4-methylamino-phenyl)-(2,3,4,5-tetrahydr...)
Affinity DataIC50:  35nMAssay Description:Inhibition of [3H]-AVP binding to human Vasopressin V2 receptor expressed in HeLa cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetVasopressin V2 receptor(Rat)
Otsuka Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50094076(CHEMBL434654 | N-[4-(7-Chloro-2,3,4,5-tetrahydro-b...)
Affinity DataIC50:  38nMAssay Description:Binding affinity of the compound towards rat Vasopressin V2 receptor after peroral administration of the compoundMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetVasopressin V2 receptor(Human)
Otsuka Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50094088(CHEMBL136790 | [2-Chloro-4-(3-methyl-pyrrolidin-1-...)
Affinity DataIC50:  51nMAssay Description:Inhibition of [3H]-AVP binding to human Vasopressin V2 receptor expressed in HeLa cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetVasopressin V2 receptor(Human)
Otsuka Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50094073((2-Chloro-4-piperidin-1-yl-phenyl)-(2,3,4,5-tetrah...)
Affinity DataIC50:  120nMAssay Description:Inhibition of [3H]-AVP binding to human Vasopressin V2 receptor expressed in HeLa cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetVasopressin V2 receptor(Rat)
Otsuka Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50094075((2-Chloro-4-pyrrolidin-1-yl-phenyl)-(2,3,4,5-tetra...)
Affinity DataIC50:  150nMAssay Description:Binding affinity of the compound towards rat Vasopressin V2 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetVasopressin V2 receptor(Rat)
Otsuka Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50094075((2-Chloro-4-pyrrolidin-1-yl-phenyl)-(2,3,4,5-tetra...)
Affinity DataIC50:  150nMAssay Description:Binding affinity against Vasopressin V2 receptor was determined in Brattleboro ratsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetVasopressin V2 receptor(Human)
Otsuka Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50094081((4-Amino-phenyl)-(2,3,4,5-tetrahydro-benzo[b]azepi...)
Affinity DataIC50:  180nMAssay Description:Inhibition of [3H]-AVP binding to human Vasopressin V2 receptor expressed in HeLa cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetVasopressin V2 receptor(Human)
Otsuka Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50094080((7-Chloro-2,3,4,5-tetrahydro-benzo[b]azepin-1-yl)-...)
Affinity DataIC50:  210nMAssay Description:Inhibition of [3H]-AVP binding to human Vasopressin V2 receptor expressed in HeLa cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetVasopressin V2 receptor(Rat)
Otsuka Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50117486(2-[(R)-1-(2-Chloro-4-pyrrolidin-1-yl-benzoyl)-2,3,...)
Affinity DataIC50:  230nMAssay Description:Binding affinity against Vasopressin V2 receptor was determined in Brattleboro ratsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetVasopressin V2 receptor(Human)
Otsuka Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50094085((4-Pyrrol-1-yl-phenyl)-(2,3,4,5-tetrahydro-benzo[b...)
Affinity DataIC50:  320nMAssay Description:Inhibition of [3H]-AVP binding to human Vasopressin V2 receptor expressed in HeLa cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetVasopressin V2 receptor(Human)
Otsuka Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50117486(2-[(R)-1-(2-Chloro-4-pyrrolidin-1-yl-benzoyl)-2,3,...)
Affinity DataIC50:  330nMAssay Description:Binding affinity of the compound against human Vasopressin V2 receptor expressed in HeLa cells was determinedMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetVasopressin V2 receptor(Rat)
Otsuka Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50117485(2-[1-(2-Chloro-4-pyrrolidin-1-yl-benzoyl)-2,3,4,5-...)
Affinity DataIC50:  390nMAssay Description:Binding affinity against Vasopressin V2 receptor was determined in Brattleboro ratsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetVasopressin V2 receptor(Human)
Otsuka Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50117485(2-[1-(2-Chloro-4-pyrrolidin-1-yl-benzoyl)-2,3,4,5-...)
Affinity DataIC50:  980nMAssay Description:Binding affinity of the compound against human Vasopressin V2 receptor expressed in HeLa cells was determinedMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetVasopressin V2 receptor(Human)
Otsuka Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50094084((4-Pyrrolidin-1-yl-phenyl)-(2,3,4,5-tetrahydro-ben...)
Affinity DataIC50:  1.00E+3nMAssay Description:Inhibition of [3H]-AVP binding to human Vasopressin V2 receptor expressed in HeLa cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetVasopressin V1a receptor(Rat)
Otsuka Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50094076(CHEMBL434654 | N-[4-(7-Chloro-2,3,4,5-tetrahydro-b...)
Affinity DataIC50:  5.10E+3nMAssay Description:Binding affinity of the compound towards rat Vasopressin V1a receptor after peroral administration of the compoundMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610865(US10626095, Example 646)
Affinity DataEC50:  620nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610866(US10626095, Example 649)
Affinity DataEC50:  2.47E+3nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610868(US10626095, Example 657)
Affinity DataEC50:  1.16E+3nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610869(US10626095, Example 659)
Affinity DataEC50:  810nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610870(US10626095, Example 663)
Affinity DataEC50:  1.25E+3nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610871(US10626095, Example 718)
Affinity DataEC50:  1.51E+3nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610872(US10626095, Example 790)
Affinity DataEC50:  980nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610873(US10626095, Example 807)
Affinity DataEC50:  1.10E+3nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610875(US10626095, Example 931)
Affinity DataEC50:  690nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610876(US10626095, Example 934)
Affinity DataEC50:  510nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610877(US10626095, Example 944)
Affinity DataEC50:  1.01E+3nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610878(US10626095, Example 989)
Affinity DataEC50:  800nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610879(US10626095, Example 1004)
Affinity DataEC50:  1.80E+3nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610880(US10626095, Example 1017)
Affinity DataEC50:  1.00E+3nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


Displayed 1 to 50 (of 223 total ) | Next | Last >>
Jump to: